Versigent PLC director Kevin P. Clark reported direct sales of 97,278 ordinary shares across five transactions on October 7 and 8, 2026. The reported weighted-average prices were $44.90, $45.68 and $46.43 per share on October 7, and $44.33 and $44.88 on October 8. The sales were made under a Rule 10b5-1 trading plan adopted by Clark on June 3, 2026 through his Kevin P. Clark 2002 Revocable Trust.
Versigent PLC (VGNT) reported that director Amy E. Alving acquired 14.65 Dividend Equivalent Rights on September 18, 2026. These rights accrued on existing restricted stock units due to a dividend declared and paid by Versigent and are each economically equivalent to one ordinary share, vesting on the same schedule as the related restricted stock units.
Versigent PLC (VGNT) director Kevin P. Clark reported an acquisition of 14.65 Dividend Equivalent Rights on September 18, 2026. These derivative rights accrued on prior restricted stock unit grants due to a dividend declared and paid by Versigent and represent the economic equivalent of 14.65 ordinary shares, vesting on the same schedule as the related RSUs.
Versigent PLC (VGNT) reported that Chief People Officer Vinci Sharon acquired 172.634 dividend equivalent rights on September 18, 2026. These rights accrued on previously granted restricted stock units due to a dividend and are economically equivalent to 172.634 ordinary shares, vesting on the same schedule as those units. No Rule 10b5-1 trading plan is reported for this grant.
Versigent PLC (symbol: VGNT) is the issuer of record for a Form 4 filing submitted to the SEC. CELIAN JASON reported acquisition or exercise transactions in this Form 4 filing.
Versigent PLC (ticker VGNT) reported that Chief Accounting Officer Celian Jason received a grant of 25.7530 Dividend Equivalent Rights on September 18, 2026. These derivative rights correspond to 25.7530 ordinary shares, vest on the same schedule as the related restricted stock units, and are held as direct ownership.
Versigent PLC (symbol: VGNT) is the issuer of record for a Form 4 filing submitted to the SEC. Ostermann Douglas R reported acquisition or exercise transactions in this Form 4 filing.
Versigent PLC (VGNT) reported that Chief Financial Officer Ostermann Douglas R received a grant of 480.603 dividend equivalent rights on September 18, 2026. These derivative rights relate to existing restricted stock unit grants and are the economic equivalent of the same number of Versigent ordinary shares.
The dividend equivalent rights accrued because Versigent declared and paid a dividend, and they will vest on the same schedule as the underlying restricted stock units. No Rule 10b5-1 trading plan is indicated for this award, and the CFO’s direct holdings of these rights increased to 480.603 following the transaction.
Versigent PLC (symbol: VGNT) is the issuer of record for a Form 4 filing submitted to the SEC. Liotine Joseph T. reported acquisition or exercise transactions in this Form 4 filing.
Versigent PLC (VGNT) reported that CEO and Director Joseph T. Liotine received an automatic grant of 489.229 dividend equivalent rights on September 18, 2026. These rights accrued on previously granted restricted stock units due to a dividend and are economically equivalent to 489.229 ordinary shares, vesting on the same schedule as the underlying units. No Rule 10b5-1 trading plan is reported.
Versigent PLC (VGNT) director Brad M. Cerepak reported an acquisition of 14.65 Dividend Equivalent Rights on September 18, 2026. These rights accrued on previously granted restricted stock units due to a dividend declared and paid by Versigent and are the economic equivalent of 14.65 ordinary shares, vesting on the same schedule as the related restricted stock units.
Versigent PLC (symbol: VGNT) is the issuer of record for a Form 4 filing submitted to the SEC. Kueppers Eric reported acquisition or exercise transactions in this Form 4 filing.
Versigent PLC (VGNT) reported that director Eric Kueppers received a grant of 14.65 Dividend Equivalent Rights on September 18, 2026. These rights accrued on earlier restricted stock unit grants due to a dividend declared and paid by Versigent and will vest on the same schedule as the related RSUs. Each right is the economic equivalent of one ordinary share.
Versigent PLC (VGNT) reported that director Tamez Armando received a grant of 14.65 Dividend Equivalent Rights on September 18, 2026. These rights accrued on existing restricted stock units due to a dividend declared and paid by Versigent and are the economic equivalent of 14.65 ordinary shares, vesting on the same schedule as the related restricted stock units.
The acquisition is recorded as a derivative award with no cash exercise price and represents a direct holding by the director. No transactions are reported as made under a Rule 10b5-1 trading plan.